Literature DB >> 23211052

Characterization of mesenchymal stem cell subpopulations from human amniotic membrane with dissimilar osteoblastic potential.

Margarita Leyva-Leyva1, Lourdes Barrera, César López-Camarillo, Lourdes Arriaga-Pizano, Gabriel Orozco-Hoyuela, Erika M Carrillo-Casas, Jaime Calderón-Pérez, Annia López-Díaz, Felipe Hernandez-Aguilar, Ricardo González-Ramírez, Simón Kawa, Jesús Chimal-Monroy, Lizeth Fuentes-Mera.   

Abstract

Human fetal mesenchymal stem cells can be isolated from the amniotic membrane (AM-hMSCs) by enzymatic digestion. The biological properties of this cell population have been characterized; however, few studies have focused on the presence of stem cell subpopulations and their differentiation potential. The aim of the present study was to isolate homogeneous AM-hMSC subpopulations based on the coexpression of surface markers. In addition, we aimed to characterize stem cell subpopulations through the detection of typical stem cell markers and its differentiation potential. In this study, fluorescence-activated cell sorting (FACS) was used to positively select for the surface markers CD44, CD73, and CD105. Two subpopulations were isolated: CD44+ / CD73+ / CD105+ (CD105+), and CD44+ / CD73+ / CD105- (CD105-). To characterize the cell subpopulations, the expression of pluripotency-associated markers was analyzed by reverse transcriptase-polymerase chain reaction and immunofluorescence. Our results showed positive expression of SOX2, SOX3, PAX6, OCT3/4, and NANOG in the CD105+ and CD105(-) cell subpopulations. In contrast, we did not detect expression of SSEA4 or FOXD3 in either subpopulation. Immunophenotypes, such as mesenchymal and hematopoietic markers, were studied by FACS analyses. Our data revealed the expression of the CD49a, CD49d, CD29, integrin α9β1, CD44, CD73, and CD105 antigens in both subpopulations. In contrast, CD90, CD45, CD34, CD14, and HLA-DR expression was not detected. The ability of both subpopulations to differentiate into osteoblasts, adipocytes, and chondrocytes was evidenced using Alizarin red, Oil-Red, and Alcian blue staining, respectively. Furthermore, neuronal differentiation was demonstrated by the expression of GFAP and NEURO-D. Interestingly, we observed a dissimilar osteoblastic differentiation potential between the subpopulations. CD105- cells showed stronger expression of secreted protein acidic and rich in cysteine (SPARC) and osteonectin, which was associated with more effective calcium deposition, than CD105+ cells. In conclusion, we described a systematic method for the isolation of hMSCs that was highly reproducible and generated homogeneous cultures for osteoblast differentiation with an efficient capacity for mineralization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23211052     DOI: 10.1089/scd.2012.0359

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  29 in total

1.  Engineering bone tissue substitutes from human induced pluripotent stem cells.

Authors:  Giuseppe Maria de Peppo; Iván Marcos-Campos; David John Kahler; Dana Alsalman; Linshan Shang; Gordana Vunjak-Novakovic; Darja Marolt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-07       Impact factor: 11.205

Review 2.  Lung-resident mesenchymal stromal cells are tissue-specific regulators of lung homeostasis.

Authors:  Stefanie Noel Sveiven; Tara M Nordgren
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-13       Impact factor: 5.464

3.  Human amnion mesenchymal stem cells promote proliferation and osteogenic differentiation in human bone marrow mesenchymal stem cells.

Authors:  Yuli Wang; Ying Yin; Fei Jiang; Ning Chen
Journal:  J Mol Histol       Date:  2014-11-29       Impact factor: 2.611

4.  A comparison of isolation and culture protocols for human amniotic mesenchymal stem cells.

Authors:  Aisha Naeem; Nikita Gupta; Usra Naeem; Muhammad Jawad Khan; Mohamed A Elrayess; Wanxing Cui; Chris Albanese
Journal:  Cell Cycle       Date:  2022-04-12       Impact factor: 5.173

5.  Isolation of human mesenchymal stem cells and their cultivation on the porous bone matrix.

Authors:  Nayeli Rodríguez-Fuentes; Olivia Reynoso-Ducoing; Ana Rodríguez-Hernández; Javier R Ambrosio-Hernández; Maria C Piña-Barba; Armando Zepeda-Rodríguez; Marco A Cerbón-Cervantes; José Tapia-Ramírez; Luz E Alcantara-Quintana
Journal:  J Vis Exp       Date:  2015-02-09       Impact factor: 1.355

Review 6.  Current View on Osteogenic Differentiation Potential of Mesenchymal Stromal Cells Derived from Placental Tissues.

Authors:  Gabriela Kmiecik; Valentina Spoldi; Antonietta Silini; Ornella Parolini
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

7.  CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities.

Authors:  Per Anderson; Ana Belén Carrillo-Gálvez; Angélica García-Pérez; Marién Cobo; Francisco Martín
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

8.  Alteration of histone acetylation pattern during long-term serum-free culture conditions of human fetal placental mesenchymal stem cells.

Authors:  Yongzhao Zhu; Xumei Song; Fei Han; Yukui Li; Jun Wei; Xiaoming Liu
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

Review 9.  Stem/progenitor cells in fetuses and newborns: overview of immunohistochemical markers.

Authors:  D Fanni; C Gerosa; C Loddo; M Castagnola; V Fanos; M Zaffanello; G Faa
Journal:  Cell Regen       Date:  2021-07-05

10.  Human Amnion-Derived Mesenchymal Stem Cells Protect Human Bone Marrow Mesenchymal Stem Cells against Oxidative Stress-Mediated Dysfunction via ERK1/2 MAPK Signaling.

Authors:  Yuli Wang; Junchi Ma; Yifei Du; Jing Miao; Ning Chen
Journal:  Mol Cells       Date:  2016-01-07       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.